Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innovus Pharmaceuticals Inc (INNVD)

Innovus Pharmaceuticals Inc (INNVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,067
  • Shares Outstanding, K 2,356
  • Annual Sales, $ 23,990 K
  • Annual Income, $ -8,280 K
  • 60-Month Beta 2.89
  • Price/Sales 0.29
  • Price/Cash Flow N/A
  • Price/Book 64.02
Trade INNVD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.14
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5000 +100.00%
on 03/21/19
11.5000 -73.91%
on 03/18/19
-2.0400 (-40.48%)
since 03/11/19
3-Month
1.5000 +100.00%
on 03/21/19
11.5000 -73.91%
on 03/18/19
-4.0350 (-57.36%)
since 01/11/19
52-Week
1.5000 +100.00%
on 03/21/19
19.3725 -84.51%
on 07/23/18
-12.9600 (-81.20%)
since 04/11/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Innovus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. It delivers non-prescription medicine and consumer care products to improve men's and women's health and vitality. It has a robust portfolio of sexual dysfunction treatments, cough, cold, respiratory disease treatments and pain...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.8867
1st Resistance Point 3.4433
Last Price 3.0000
1st Support Level 2.6033
2nd Support Level 2.2067
3rd Support Level N/A

See More

52-Week High 19.3725
Fibonacci 61.8% 12.5452
Fibonacci 50% 10.4362
Fibonacci 38.2% 8.3273
Last Price 3.0000
52-Week Low 1.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar